Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
002370 Zhejiang Yatai Pharmaceutical
- 3.61
- +0.02+0.56%
Market Closed Dec 20 15:00 CST
2.57BMarket Cap-156.96P/E (TTM)
3.62High3.57Low319.15KlotVolume3.58Open3.59Pre Close114.65MTurnover4.48%Turnover RatioLossP/E (Static)712.84MShares4.3852wk High4.55P/B2.57BFloat Cap2.2152wk Low3.95Limit Up712.84MShs Float22.10Historical High3.23Limit Down1.39%Amplitude2.21Historical Low--Dividend TTM3.59Avg Price171.49KlotAsk--Div YieldTTM100Lot Size147.38KlotBid
Zhejiang Yatai Pharmaceutical News
Asia Pacific Pharmaceutical: Notice on the Company\'s Obtaining a Notice of Approval of the Drug Supplement Application
Asia Pacific Pharmaceutical: China Investment Securities Co., Ltd.\'s verification opinion on Zhejiang Asia Pacific Pharmaceutical Co., Ltd. terminating a fund-raising investment project with convertible bonds
Asia Pacific Pharmaceutical: Announcement on the cumulative amount of debt-for-equity swaps of Asia Pharmaceuticals reaching 10% of the total amount of shares issued by the company before the share conversion
Asia Pacific Pharmaceutical: Announcement on the termination of the convertible bond fund-raising investment project
Asia Pacific Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Asia Pacific Pharmaceutical: Announcement on the cumulative amount of debt-for-equity swaps of Asia Pharmaceuticals reaching 10% of the total amount of shares issued by the company before the share conversion
Asia Pacific Pharmaceutical: Progress Announcement on Wholly-owned Subsidiaries Providing Guarantees for the Company\'s Financing
Asia Pacific Pharmaceuticals: Notice on Receipt of Civil Judgment
Asia Pacific Pharmaceutical: Announcement on the freezing of the company\'s bank account
Asia Pacific Pharmaceutical: Notice on receiving the acceptance notice for the consistency evaluation of diltiazem hydrochloride tablets
Asia Pacific Pharmaceutical: Announcement on Atomic Company\'s completion of the registration of capital reduction and commercial changes
Asia Pacific Pharmaceutical: Announcement on the progress of liquidation and cancellation of joint ventures
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024
Asia Pacific Pharmaceutical: Announcement on Sale of 100% Shares in Wholly-owned Subsidiaries and Debt Forgiveness
Asia Pacific Pharmaceutical: Progress Notice on Litigation Matters
Asia Pacific Pharmaceutical: Notice on receiving the acceptance notice for the consistency evaluation of atenolol tablets
Zhejiang Yatai Pharmaceutical: Financial Report for the first half of 2024.
Zhejiang Yatai Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Zhejiang Yatai Pharmaceutical: Announcement Regarding Not Lowering the Conversion Price of Yayao Convertible Bonds to Equity
Zhejiang Yatai Pharmaceutical: Announcement on changing the continuously supervised sponsoring representative.
